GlassScriptPhysician profile
Brian Adcock
NPI 1194725788
$4,733.78
in general payments reported to CMS, 2019-2025
29 companies · $214 in 2025
The $214 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $602 · 2022: $835 · 2023: $1,762 · 2024: $1,322 · 2025: $214.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,133 · Education: $164.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,133.02 |
| Education | $164.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $672.92 | 2022-2024 | Erleada, Akeega |
| Astellas Pharma US INC | $640.46 | 2021-2024 | Xtandi |
| Sumitomo Pharma America, INC. | $632.45 | 2023-2025 | Gemtesa, Orgovyx |
| Dendreon Pharmaceuticals LLC | $246.10 | 2023-2025 | Provenge |
| Procept Biorobotics Corporation | $239.68 | 2023 | Aquabeam Robotic System |
| Abbvie INC. | $234.98 | 2021-2024 | Botox, Lupron Depot |
| Merck Sharp & Dohme LLC | $213.60 | 2022-2024 | Lynparza, Keytruda, Welireg |
| Myriad Genetic Laboratories, INC. | $209.26 | 2021-2024 | Prolaris, Myrisk |
| Olympus America INC. | $175.15 | 2023-2024 | Itind System |
| Medtronic, INC. | $169.98 | 2021-2025 | Interstim, Altaviva |
| Antares Pharma, INC. | $168.78 | 2021-2024 | Xyosted, Tlando, Nocdurna |
| Urovant Sciences INC | $132.59 | 2022 | |
| Ethicon INC. | $116.66 | 2021 | |
| Ferring Pharmaceuticals INC. | $115.91 | 2024-2025 | Adstiladrin |
| Urogen Pharma, INC. | $108.84 | 2022-2023 | Jelmyto |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $91.87 | 2021-2024 | Aveed, Edex, Xiaflex |
| Pfizer INC. | $78.53 | 2022-2024 | |
| Clarus Therapeutics INC. | $78.18 | 2021 | |
| Coloplast Corp | $65.11 | 2022-2024 | Speedicath |
| Teleflex LLC | $51.82 | 2023-2024 | Urolift |
| Blue Earth Diagnostics | $47.54 | 2024 | |
| Endo USA, INC. | $41.33 | 2024 | Xiaflex, Aveed, Edex |
| Myovant Sciences INC. | $39.99 | 2021-2022 | |
| Tolmar, INC. | $39.29 | 2023 | |
| Accord Healthcare, INC. | $34.86 | 2022-2023 | |
| Axonics, INC. | $31.23 | 2023 | Bulkamid |
| Novartis Pharmaceuticals Corporation | $25.17 | 2022 | |
| Telix Pharmaceuticals | $17.79 | 2025 | Illuccix |
| Rochester Medical Corporation | $13.71 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Adcock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.